Asston Pharmaceuticals Ipo
Objects of the Issue
Funding capital expenditure requirements towards acquiring machinery in the manufacturing unit
Funding the incremental working capital requirements of the Company
Repayment and/or prepayment, in part or full, of certain of the outstanding borrowings availed by the Company
General Corporate Purposes
Asston Pharmaceuticals IPO Review
Canara Bank –
DRChoksey FinServ –
Emkay Global –
Hem Securities –
IDBI Capital –
Marwadi Shares –
Nirmal Bang –
SBICAP Securities –
Sharekhan –
SMC Global –
Sushil Finance –
Swastika Investmart –
Ventura Securities –
Geojit –
Reliance Securities –
Capital Market –
BP Wealth –
ICICIdirect –
Choice Broking –
IPO Lead Managers aka Merchant Bankers
Sobhagya Capital Options Ltd
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 2 | 2,000 | ₹2,46,000 |
| Retail Maximum | 2 | 2,000 | ₹2,46,000 |
| S-HNI Minimum | 3 | 3,000 | ₹3,69,000 |
| IPO Open Date: | July 9, 2025 |
| IPO Close Date: | July 11, 2025 |
| Basis of Allotment: | July 14, 2025 |
| Refunds: | July 15, 2025 |
| Credit to Demat Account: | July 15, 2025 |
| IPO Listing Date: | July 16, 2025 |
| Period Ended | Revenue | Expense | Profit After Tax | Assets |
| 2023 | ₹7.19 | ₹5.78 | ₹1.06 | ₹13.69 |
| 2024 | ₹15.84 | ₹14.02 | ₹1.36 | ₹20.26 |
| 2025 | ₹25.61 | ₹19.91 | ₹4.33 | ₹28.12 |
| May 2025 | ₹6.21 | ₹4.44 | ₹1.32 | ₹31.83 |
| KPI | Values |
| ROE: | 50.56% |
| ROCE: | 51.25% |
| EBITDA Margin: | 24.60% |
| PAT Margin: | 17.27% |
| Debt to equity ratio: | 0.68 |
| Earning Per Share (EPS): | ₹6.90 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 40.36% |
| Net Asset Value (NAV): | ₹17.09 |
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Shelter Pharma Limited | 6.26 | 6.70 | 16.94% | 36.96 | – Cr. |
| Bafna Pharmaceuticals Limited | 1.76 | 51.38 | 4.89% | 35.86 | – Cr. |
| Trident Lifeline Limited | 11.35 | 25.29 | 19.85% | 57.16 | – Cr. |
| IPO Open Date: | July 9, 2025 |
| IPO Close Date: | July 11, 2025 |
| Face Value: | ₹10 Per Equity Share |
| IPO Price Band: | ₹115 to ₹123 Per Share |
| Issue Size: | Approx ₹27.56 Crores |
| Fresh Issue: | Approx ₹27.56 Crores |
| Issue Type: | Book Build Issue |
| IPO Listing: | BSE SME |
| Retail Quota: | Not more than 35% |
| QIB Quota: | Not more than 50% |
| NII Quota: | Not more than 15% |
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | Click Here |
| Anchor Investors List: | Click Here |